Back to search results

Virtual Reality Gait Rehabilitation for Stroke Survivors

This study is testing two virtual reality (VR) programs to help stroke survivors improve their walking. One program uses fully-immersive, real-world environments for walking overground (Walk-over-Ground). The other uses semi-immersive, game-like environments for treadmill walking (C-Mill VR+ by Motek). We are looking for people aged 18 and older who have had an ischemic or hemorrhagic stroke 1-6 months ago and have moderate walking impairment. The study will measure how far and how much you walk to see which program is more effective. The current status of this study is unclear, and it plans to enroll 30 participants.

Study design
This is an interventional study that plans to enroll 30 participants. You would be randomly assigned to one of the two VR rehabilitation groups.
What's involved
You would wear a tracker for at least 5 days before starting treatment. Then, you would have 12 treatment sessions, twice a week for 6 weeks. Assessments are done before treatment, after treatment, and one month later.
Compensation
Not stated in the trial record.
Follow-up
You would be followed for one month after your treatment ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07676578

Overground Virtual Reality (VR) Gait Rehabilitation for Stroke

Recruiting
NAAges 18+InterventionalTreatment
Indiana University
~30 participants
Updated 2026-08-17 on ClinicalTrials.gov
What's tested:Walk-over-GroundC-Mill VR+ by Motek

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Step Count
Measured over Continuous tracking from Screening to Week 10
+2 more outcomes measured

Conditions

Stroke

Explore related trials

Stroke

NCT07676578

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Indiana University Health, Neurorehabilitation & Robotics

    Indianapolis, Indianastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Hee-Tae Jung, Ph.D. · PRINCIPAL_INVESTIGATOR · Indiana University, Luddy School of Informatics, Computing, and Engineering
  • Peter Altenburger, Ph.D., PT · PRINCIPAL_INVESTIGATOR · Indiana University, School of Health & Human Sciences; Indiana University Health, Center for Advanced Neurorehabilitation

Who to contact

Peter Altenburger, Ph.D., PT
[email protected]
317-278-0703
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis: Anischemic or hemorrhagic stroke verified by imaging, confirmed by the patient's physician, and 1-6 months post-stroke (subacute phase)
Motor Impairment Level: Functional Ambulation Category (FAC) 3-5, showing moderate impairment while still allowing safe participation in gait tasks.
Cognitive Function: Mini-Mental State Examination (MMSE) score ≥ 24 or Montreal Cognitive Assessment (MoCA) score \>= 20, indicating sufficient cognitive function to participate in the study.
Exercise Clearance: Approval from a physician for participation in exercise- and VR-based interventions.
Rehabilitation Need: 10-Meter Walk Test \<1.0 m/s, as timed by a PT during screening, indicating a need for functional rehabilitation.
Consent: Must be able to provide informed consent for themselves.

Exclusion

Participants with uncontrolled cardiovascular, orthopedic, or metabolic conditions or unstable medication regimens that could interfere with their participation in the study.
Any comorbidity that could interfere with walking or gait training.
Participation in robot- or VR-assisted gait training within the last 6 months.
Intolerance to virtual reality environments or motion simulation.
Severe cognitive, visual, or hearing impairments where the participant cannot follow the therapist's instructions.
Any other condition deemed unsafe or confounding by investigator, such as pre-existing neurological conditions unrelated to stroke (e.g. Parkinson's, multiple sclerosis), unmanaged pain medications, or acute medical events during the screening period (e.g. recurrent stroke, hospitalization).
Individuals who score a 12 or higher on the Disability Rating Scale.
Recent Therapy: Participants should not have received physical therapy (PT) within the last month.

What this trial measures

  • Step CountContinuous tracking from Screening to Week 10

    FitBit tracks the number of steps (count) taken by participant.

  • Travel DistanceContinuous tracking from Screening to Week 10

    FitBit tracks the total distance (miles) travelled by participant.

  • Activity Zone MinutesContinuous tracking from Screening to Week 10

    Fitbit calculates maximum heart rate (HR) from user age (Max HR = 220 - age) and defines Activity Zone thresholds based on percentages of max HR (Fat Burn 50-69%, Cardio/Peak \>70%). Activity Zone Minutes (AZMs) are an intensity-weighted measure of activity. AZM (count) is based on sustained heart rate over time: 1 AZM per minute in the Fat Burn Zone (50-69% max HR) and 2 AZMs per minute in the Cardio/Peak Zones (\>=70% max HR).